Skip to content
Catalyst

PapersPMID:42227307

Vitamin B12 supplementation for growth, development, and cognition in children.

The Cochrane database of systematic reviews2026The record ↗

  1. Finding, very limited evidenceraisesSerum vitamin B12 (cobalamin) concentration

What moved

1 findingHow to read these marks →
  • “Vitamin B12 supplementation in children reduces vitamin B12 deficiency (absolute risk difference (ARD) 56 fewer per 1000, 95% CI 68 fewer to 24 fewer; 1.8% versus 7.6%; risk ratio (RR) 0.27, 95% CI 0.11 to 0.69; 3 trials, 642 children; high-certainty evidence), and probably increases total vitamin B12 concentrations (MD 68.53 pmol/L, 95% CI 41.83 to 95.23; 7 trials, 705 children; moderate-certainty evidence), compared to placebo, with an average increase of 68.5 pmol/L.”
    Study
    meta-analysis
    Participants
    705
    Effect
    68.53 mean difference, 95% CI 41.83 to 95.23
    Population
    Children under 12 years in randomised trials of oral vitamin B12 alone versus placebo, pooled

Study record

Design
meta-analysis
Species
human
Population
Children less than 12 years of age
Participants
4,083
Comparator
placebo
Duration
not reported
Endpoints measured
13
Declined
this platform holds no node for the endpoint